Health Solutions
My video

Additional Info

  • Item Shortcode:


Osteoarthritis (OA) is a degenerative joint disease that frequently affects the hands and weight bearing joints of the body.

There is a wide spectrum of non-surgical treatments, starting with non-pharmacological options such as patient education and awareness, physical exercise and rehabilitation aids; pharmacological approaches that vary from prescription of acetaminophen, non-selective NSAIDs, selective COX-2 inhibitors agents and even opioid prescription.

Other potential non-surgical therapeutic methods are chondroitin sulfate, glucosamine, and intraarticular injections of visco-supplements, corticosteroids or blood-derived products.

Each injection has been shown to lower the pain in patients in some form, though hyaluronic acid treatments seem to be the safest and last the longest.

Carthyal® is an injectable hyaluronic acid that can substitute the synovial fluid and it is indicated in the prevention and treatments of trauma-caused and degenerative diseases in synovial joints.

The intra-articular administration of Carthyal® allows:

  • Immediate action by REDUCING the pain and inflammation
  • Highly effective RESTORATION of the viscoelastic properties of the joints’ synovial fluid
  • IMPROVEMENT of the articular mobility, with functional recovery of the joint
  • PREVENTION the natural degradation of the joints
  • SAFE, WIDELY documented treatment with less side effect

CARTHYAL® is available in 3 different active concentration, different molecular weights and treatment options:

Carthyal® ONE 2,5% (75mg/3ml):

  • Cross-linked intercalated with linear hyaluronic acid, with a combined molecular weight of 3.000.000 Da (crossed linked HA fraction) + 500.000 Da (linear HA faction)
  • Treatement with 1 injection

Carthyal® PLUS 1,6% + 5% MSM (32mg/2ml HA + 100mg/2ml Methylsulfonylmethane):

  • Sodium Hyaluronate with a molecular weight of 1.800.000 Da
  • Treatement with 3 injections 2 weeks apart (T0 – T2 – T4)

• Carthyal® 2% (40mg/2ml):

  • Sodium Hyaluronate with a molecular weight between 800.000 and 1.200.000 Da
  • Treatement with 3 injections 2 weeks apart (T0 – T2 – T4)

Carthyal® line of products are European Medical Devices class III, produced in the E.U. under ISO 13485 with 24 months shelf life.

© 2017 Neosanté - Health Solutions

Privacy PolicyCookies Policy
Designed by MM Design